PMID- 20825413 OWN - NLM STAT- MEDLINE DCOM- 20110318 LR - 20211020 IS - 1750-3639 (Electronic) IS - 1015-6305 (Print) IS - 1015-6305 (Linking) VI - 21 IP - 1 DP - 2011 Jan TI - Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. PG - 16-30 LID - 10.1111/j.1750-3639.2010.00426.x [doi] AB - Infiltration of leukocytes into post-ischemic cerebrum is a well-described phenomenon in stroke injury. Because CD-8(+) T-lymphocytes secrete cytotoxic proteases, including granzyme-b (Gra-b) that exacerbates post-ischemic brain damage, we investigated roles of Gra-b in human stroke. To study the role of Gra-b in stroke, ischemic and non-ischemic tissues (from post-mortem stroke patients) were analyzed using immunoblotting, co-immunoprecipitation, terminal deoxy uridine nick end labeling (TUNEL) and Annexin-V immunostaining, and in vitro neuron survival assays. Activated CG-SH cells and supernatants were used to model leukocyte-dependent injury. Non-ischemic brain tissues were used as non-pathological controls. Non-activated CG-SH cells and supernatants were used as controls for in vitro experiments. Human stroke (ischemic) samples contained significantly higher levels of Gra-b and interferon-gamma inducible protein-10 (IP-10/CXCL10) than non-ischemic controls. In stroke, poly (ADP-ribose) polymerase-1 and heat shock protein-70 were cleaved to canonical proteolytic "signature" fragments by Gra-b. Gra-b was also found to bind to Bid and caspase-3. Gra-b also co-localized with Annexin-V(+) /TUNEL(+) in degenerating neurons. Importantly, Gra-b inhibition protected both normal and ischemia-reperfused neurons against in vitro neurotoxicity mediated by activated CG-SH cells and supernatants. These results suggest that increased leukocyte infiltration and elevated Gra-b levels in the post-stroke brain can induce contact-dependent and independent post-ischemic neuronal death to aggravate stroke injury. CI - (c) 2010 The Authors; Brain Pathology (c) 2010 International Society of Neuropathology. FAU - Chaitanya, Ganta Vijay AU - Chaitanya GV AD - Department of Molecular and Cellular Physiology, School of Medicine, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, La, USA. FAU - Eeka, Prabhakar AU - Eeka P FAU - Munker, Reinhold AU - Munker R FAU - Alexander, Jonathan Steven AU - Alexander JS FAU - Babu, Phanithi Prakash AU - Babu PP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Brain Pathol JT - Brain pathology (Zurich, Switzerland) JID - 9216781 RN - 0 (CXCL10 protein, human) RN - 0 (Chemokine CXCL10) RN - EC 3.4.21.- (Granzymes) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Adult MH - Aged MH - Analysis of Variance MH - Apoptosis MH - Blotting, Western MH - Brain/*metabolism/pathology MH - Brain Ischemia/*metabolism/pathology MH - Caspase 3/metabolism MH - Cell Line, Tumor MH - Cells, Cultured MH - Chemokine CXCL10/metabolism MH - Female MH - Granzymes/*metabolism MH - Humans MH - Immunohistochemistry MH - Immunoprecipitation MH - In Situ Nick-End Labeling MH - Male MH - Middle Aged MH - Necrosis MH - Nerve Degeneration/*metabolism/pathology MH - Neurons/metabolism/pathology MH - Stroke/*metabolism/pathology PMC - PMC8094313 COIS- The authors declare no conflict of interest. EDAT- 2010/09/10 06:00 MHDA- 2011/03/19 06:00 PMCR- 2010/12/03 CRDT- 2010/09/10 06:00 PHST- 2010/09/10 06:00 [entrez] PHST- 2010/09/10 06:00 [pubmed] PHST- 2011/03/19 06:00 [medline] PHST- 2010/12/03 00:00 [pmc-release] AID - BPA426 [pii] AID - 10.1111/j.1750-3639.2010.00426.x [doi] PST - ppublish SO - Brain Pathol. 2011 Jan;21(1):16-30. doi: 10.1111/j.1750-3639.2010.00426.x.